A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor (Q28342001)

6 July 2017

1 reference

title

A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor (English)

1 reference

6 July 2017

1 reference

1 reference

J F Waterfall

1

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

British Journal of Clinical Pharmacology

6 July 2017

published in

1 reference

6 July 2017

volume

27 Suppl 2

1 reference

6 July 2017

page(s)

139S-150S

1 reference

Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

The pharmacologic alteration of renin release.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

The physiological disposition and metabolism of enalapril maleate in laboratory animals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Escherichia coli mutants defective in dipeptidyl carboxypeptidase

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

A rapid and simple spectrophotometric assay of angiotensin-converting enzyme

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Antihypertensive effect of propranolol at rest and during exercise

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Inhibition of angiotensin-converting enzym by derivaties of 3-mercapto-2-methyloropanoyl glycine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Method for measuring the duration of inhibition of angiotensin I-converting enzyme in vivo

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446)

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Acute effects of captopril on the baroreflex of normotensive and spontaneously hypertensive rats.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379741

Measurement of blood pressure in unanaesthetized rats and mice

2 June 2018

1 reference

12 December 2020

Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys

1 reference

12 December 2020

Exercise induced changes of catecholamines and potassium in plasma of dogs after treatment with propranolol

1 reference

12 December 2020

Baroreceptor reflex in the rat after converting enzyme inhibition or angiotensin receptor blockade

1 reference

12 December 2020

Cardiovascular Effects of Tiapamil (Ro 11–1781), a New Calcium-Entry Blocker

1 reference

12 December 2020

New potent inhibitors of angiotensin converting enzyme

1 reference

12 December 2020

Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme

1 reference

12 December 2020

Converting enzyme inhibition in mild and moderate essential hypertension. II

1 reference

12 December 2020

Physical performance during sustained converting enzyme inhibition with Hoe 498 in conscious dogs

1 reference

12 December 2020

10.1111/J.1365-2125.1989.TB03475.X

Identifiers

DOI

1 reference

6 July 2017

1 reference

6 July 2017

1 reference